Evidence map›Paper›PMID 38914686›Full record

ArticleEuropean journal of human genetics : EJHG2025

Mild phenotypes in patients with different deletions in the 3' enhancer region of SHOX.

Valancy Miranda, Pascale Sabeh, Cristian Seiltgens, Sirinart Molidperee, Chantal Janelle, Emmanuelle Lemyre, Philippe M Campeau

Abstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Valancy MirandaShriners Hospital for Children, Montreal, QC, Canada.ORCID 0000-0002-6344-1968
Pascale SabehSainte Justine University Health Centre, Montreal, QC, Canada.ORCID 0009-0007-4201-3386
Cristian SeiltgensShriners Hospital for Children, Montreal, QC, Canada.ORCID 0000-0002-8321-5319
Sirinart MolidpereeSainte Justine University Health Centre, Montreal, QC, Canada.
Chantal JanelleShriners Hospital for Children, Montreal, QC, Canada.
Emmanuelle LemyreSainte Justine University Health Centre, Montreal, QC, Canada.
Philippe M CampeauShriners Hospital for Children, Montreal, QC, Canada. p.campeau@umontreal.ca.ORCID 0000-0001-9713-7107

Funding

Fonds de Recherche du Québec - Santé (Fonds de la recherche en sante du Quebec) 313617
6 · The paper itself

Abstract

Haploinsufficiency of the short stature homeobox-containing (SHOX) gene leads to a phenotypic spectrum ranging from Leri-Weill dyschondrosteosis (LWD) to SHOX-deficient short stature. SHOX nullizygosity leads to Langer mesomelic dysplasia. Pathogenic variants can include whole or partial gene deletions or duplications, point mutations within the coding sequence, and deletions of upstream and downstream regulatory elements. Here we report two families: a non-consanguineous family with a deletion downstream of SHOX, in which the homozygous proband presented with isolated Madelung deformity, without LWD or short stature, as well as a 9-year-old girl with Madelung deformities, mesomelia, a dominant family history of Madelung deformity and a heterozygous deletion of the CNE9 region in the 3' downstream region of SHOX. These case reports provide additional information on the effects of 3' downstream deletions of SHOX, by demonstrating the limited phenotype associated with the recurrent 47.5 kb deletion in a homozygous state and the CNE9 deletion in a heterozygous state.

Indexed as

Enhancer Elements, GeneticGrowth DisordersOsteochondrodysplasiasPhenotypeSequence DeletionShort Stature Homeobox ProteinAdolescentChildFemaleHaploinsufficiencyHomozygoteHumansMalePedigreeShort Stature Homeobox ProteinSHOX protein, human

Identifiers

PMID38914686
PMCPMC12669571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.